Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management

Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management

Schweizer E; Rickels K

Acta Psychiatrica Scandinavica, Supplementum

1998

Treatment Outcome; Anti-Anxiety Agents; Syndrome; Human; Animal; Anti-Anxiety Agents; Anxiety Disorders/dt [Drug Therapy]; Substance Withdrawal Syndrome/di [Diagnosis]; Substance-Related Disorders/di [Diagnosis]; Anxiety Disorders/px [Psychology]; Benzodiazepine; Benzodiazepine/ae [Adverse Effects]; Benzodiazepine/tu [Therapeutic Use]; Substance Withdrawal Syndrome/rh [Rehabilitation]; Substance-Related Disorders/rh [Rehabilitation]

The treatment of anxiety has evolved through various phases. Currently, there is a growing recognition that anxiety disorders are frequently chronic and/or recurrent. There is also less optimism than a decade ago that benzodiazepines will be replaced by alternative agents that are not active at the benzodiazepine receptor. Consequently, the understanding and management of benzodiazepine dependence and withdrawal continue to be of some clinical importance. This article briefly reviews the withdrawal syndrome and the pharmacological and patient variables that contribute to it. It then summarizes the various approaches to managing benzodiazepine dependence and withdrawal. [References: 39]

1998

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog